Beyond the Abstract - Second-line therapy for refractory renal-cell carcinoma ... UroToday Worth mentioning is the opportunity to use sorafenib as first-line in selected patient populations such as the elderly or patients with comorbidities including hypertension, left ventricular ejection fraction abnormalities, and renal failure.

...